The mechanism by which BRafV600E enhances ERK3 transcription is not known, but knockdown of BRafV600E in the melanoma cell line A375 or inhibition of MEK1/2, but not p38MAPK by respectively U0126 and SB203580, abrogated ERK3 expression. The gene discussed is MAPK6; the disease is melanoma.